E89R
TEAS SECTION 8 & 9 RECEIVED
08/04/2026
Back to search
Official data from USPTO
BENDEKA (BENDAMUSTINE HCI) INJECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
08/04/2026
Trademark type
Combined
Nice classes
44
Filing date
11/20/2015
Registration date
08/02/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2023
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/27/2016
First use in commerce
04/27/2016
Drawing code
3
Owner type
27
Owner location
West Chester, PA, CH
Examiner
VOHRA, SANJEEV KUMAR
Law office
M10
Current location
TMO LAW OFFICE 110
Mark description
The mark consists of the word "BENDEKA" in black capital letters with the words "bendamustine HCI" in lower case gray letters directly underneath in parenthesis and the word "injection" in lower case letters in gray directly underneath. There is a tilted triangle shape of gray ribbons directly to the left of the word "BENDEKA".
Holders and representatives
Holders
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Cephalon, Inc.
Representatives
Lori Wolfe TEVA PHARMACEUTICALS USA, INC.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma
Publications
History of USPTO decisions and trademark events.
46 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/02/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/17/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/17/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/17/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/02/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/02/2023
E815
TEAS SECTION 8 & 15 RECEIVED
08/02/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/02/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/14/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/14/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/29/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/28/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/27/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/25/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/25/2016
IUAF
USE AMENDMENT FILED
06/01/2016
EISU
TEAS STATEMENT OF USE RECEIVED
06/01/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/03/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2016
PUBO
PUBLISHED FOR OPPOSITION
03/08/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/03/2016
ALIE
ASSIGNED TO LIE
02/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/29/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
12/27/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/27/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
12/27/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/27/2015
DOCK
ASSIGNED TO EXAMINER
12/16/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/26/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2015
NWAP
NEW APPLICATION ENTERED
11/24/2015
Continuous trademark protection
Get notified about every new filing that threatens BENDEKA (BENDAMUSTINE HCI) INJECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.